As of now, bridging studies for Covovax are underway in India. SII, Gennova Biopharmaceuticals is another company based in Pune that has developed India’s first mRNA Covid-19 vaccine called HGC019. Additionally, Bharat Biotech’s nasal vaccine candidate is currently under Phase I trials.
Hyderabad-based Biological E has developed a vaccine candidate called Corbevax which is currently undergoing Phase 3 clinical trials. Thirty-crore doses of Corbevax are expected to be rolled out between August and December. Along with this, Biological E is also bringing Johnson and Johnson’s Covid-19 vaccine to India. In India, six companies will produce Russia’s Covid vaccine Sputnik V. Furthermore, Indian companies are also looking to use their manufacturing capabilities to ramp up the production of foreign vaccines via technology transfer.